Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22298)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol 2015; 21(26): 7988-8003 [PMID: 26185370 DOI: 10.3748/wjg.v21.i26.7988] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i26/7988.htm |
| Number | Citing Articles |
| 1 |
Yuwen Bao, Mengdie Zhang, Pengfei Wu, Yingpeng Wang, Bin Wan, Xin Li, Haixia Ding. Cost-effectiveness of open pancreaticoduodenectomy with or without Heidelberg TRIANGLE operation for pancreatic cancer in China. Journal of Cancer Research and Clinical Oncology 2023; 149(18): 16705 doi: 10.1007/s00432-023-05406-6
|
| 2 |
Ramesh Khadka, Weijun Tian, Xin Hao, Rakshya Koirala. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review. International Journal of Surgery 2018; 52: 342 doi: 10.1016/j.ijsu.2018.02.058
|
| 3 |
Ming Xu, Jie Tang, Qiong Sun, Jing Meng, Guoyu Chen, Yunli Chang, Yao Yao, Jieru Ji, Hao Luo, Lingling Chen, Minxue Lu, Weiwei Shi. CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway. Archives of Medical Science 2024; doi: 10.5114/aoms/171956
|
| 4 |
Wesley dos Santos, Fábia Cheyenne Gomes de Morais Fernandes, Dyego Leandro Bezerra de Souza, Kezauyn Miranda Aiquoc, Ana Mayara Gomes de Souza, Isabelle Ribeiro Barbosa. Pancreatic cancer incidence and mortality trends: a population-based study. Revista de Salud Pública 2022; 24(1): 1 doi: 10.15446/rsap.v24n1.89397
|
| 5 |
Cheng Fei, Jianxu Luo. DTUnet: A Transformer-based UNet Combined with DenseASPP Module for Pancreas Segmentation. 2022 15th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI) 2022; : 1 doi: 10.1109/CISP-BMEI56279.2022.9980137
|
| 6 |
Tianying Zheng, Wenfei Han, Aijun Wang, Yonggang Wang. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. PeerJ 2022; 10: e12802 doi: 10.7717/peerj.12802
|
| 7 |
Fei Cao, Feng Li, Lei Shi, Guoyao Zhang, Lei Zhang, Tianjiang Ma, Kexun Zhang. Spatial and Temporal Trends in Pancreatic Cancer Burden Attributable to High Body Mass Index at the Global and National Levels. Journal of Epidemiology and Global Health 2023; 13(4): 831 doi: 10.1007/s44197-023-00155-8
|
| 8 |
Jiaqi Chen, Hui Chen, Tongchao Zhang, Xiaolin Yin, Jinyu Man, Xiaorong Yang, Ming Lu. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Pancreatology 2022; 22(5): 608 doi: 10.1016/j.pan.2022.04.011
|
| 9 |
Diogo Oliveira Chaves, Aline Cândida Bastos, Alessandra Maciel Almeida, Maximiliano Ribeiro Guerra, Maria Teresa Bustamante Teixeira, Ana Paula Souto Melo, Valéria Maria de Azeredo Passos. The increasing burden of pancreatic cancer in Brazil from 2000 to 2019: estimates from the Global Burden of Disease Study 2019.. Revista da Sociedade Brasileira de Medicina Tropical 2022; 55( suppl 1) doi: 10.1590/0037-8682-0271-2021
|
| 10 |
Qingyun Zhu, Xinting Pan, Yunbo Sun, Zhengbin Wang, Fuguo Liu, Aiqin Li, Zhihui Zhao, Yunlong Wang, Kun Li, Liangyu Mi, Jose G. Trevino. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo. PLOS ONE 2017; 12(10): e0185507 doi: 10.1371/journal.pone.0185507
|
| 11 |
Qiangfeng Yu, Zhe Xiu, Yizeng Jian, Jianyin Zhou, Xiaopeng Chen, Xiang Chen, Chunxiang Chen, Hongbao Chen, Sijia Yang, Libo Yin, Wenlong Zeng. microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1. Aging 2022; 14(14): 5908 doi: 10.18632/aging.204193
|
| 12 |
Tian-Dong Li, Hong-Wei Yang, Peng Wang, Chun-Hua Song, Kai-Juan Wang, Li-Ping Dai, Jian-Xiang Shi, Jian-Ying Zhang, Hua Ye. Coffee consumption and risk of pancreatic cancer: a systematic review and dose–response meta-analysis. International Journal of Food Sciences and Nutrition 2019; 70(5): 519 doi: 10.1080/09637486.2018.1551337
|
| 13 |
Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu, Ping Bie. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1340-7
|
| 14 |
Jinghao Lei, Qiang Wang, Tengfei Qu, Lichao Cha, Hanxiang Zhan, Jianwei Xu, Shanglong Liu, Lantian Tian, Chuandong Sun, Jingyu Cao, Fabo Qiu, Weidong Guo, Bin Zhou. KCNH2 regulates the growth and metastasis of pancreatic cancer. Journal of Pancreatology 2023; 6(3): 101 doi: 10.1097/JP9.0000000000000123
|
| 15 |
Kai Qu, Xing Zhang, Ting Lin, Tian Liu, Zhixin Wang, Sushun Liu, Lei Zhou, Jichao Wei, Hulin Chang, Ke Li, Zheng Wang, Chang Liu, Zheng Wu. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01904-z
|
| 16 |
宇 何. Research Progress of Palliative Care for Patients with Advanced Pancreatic Cancer. Advances in Clinical Medicine 2021; 11(07): 3117 doi: 10.12677/ACM.2021.117452
|
| 17 |
Xiao Yu, Qiyao Zhang, Shuijun Zhang, Yuting He, Wenzhi Guo. Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1000447
|
| 18 |
Qun Chen, Wu-Jun Wang, Yun-Xuan Jia, Hao Yuan, Peng-Fei Wu, Wan-Li Ge, Ling-Dong Meng, Xu-Min Huang, Peng Shen, Tao-Yue Yang, Yi Miao, Jing-Jing Zhang, Kui-Rong Jiang. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00602-8
|
| 19 |
Lei Wang, Rongrong Bi, Lei Li, Kun Zhou, Hang Yin. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy. Aging 2021; 13(15): 19272 doi: 10.18632/aging.203251
|
| 20 |
Cong-Ying Song, Yan Shen, Yuan-Qiang Lu. Role of routine check-up in the prognosis of patients with pancreatic cancer: A puzzling phenomenon. Hepatobiliary & Pancreatic Diseases International 2021; 20(1): 67 doi: 10.1016/j.hbpd.2020.06.009
|
| 21 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|
| 22 |
Quan‐Jun Lin, Zhi‐Bo Xie, Ya Gao, Yi‐Fan Zhang, Lie Yao, De‐Liang Fu. LyP‐1‐fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells. Journal of Cellular and Molecular Medicine 2020; 24(5): 2891 doi: 10.1111/jcmm.14864
|
| 23 |
Yuancong Jiang, Qin Chen, Zhize Wang, Yi Shao, Chen Hu, Yuan Ding, Zhenhua Shen, Ming Jin, Sheng Yan. The Prognostic Value of External vs Internal Pancreatic Duct Stents in CR-POPF after Pancreaticoduodenectomy: A Systematic Review and Meta-analysis. Journal of Investigative Surgery 2021; 34(7): 738 doi: 10.1080/08941939.2019.1691687
|
| 24 |
Xin Wang, Qingqing Yu, Xue Bai, Xinyu Li, Yanli Sun, Xiaoxiang Peng, Ronglan Zhao. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers. European Journal of Cancer Prevention 2024; 33(3): 271 doi: 10.1097/CEJ.0000000000000851
|
| 25 |
Yehua Shen, Litao Xu, Zhouyu Ning, Luming Liu, Junhua Lin, Hao Chen, Zhiqiang Meng. ARHGAP4 regulates the cell migration and invasion of pancreatic cancer by the HDAC2/β-catenin signaling pathway. Carcinogenesis 2019; 40(11): 1405 doi: 10.1093/carcin/bgz067
|
| 26 |
Weiping Ji, Kailian Zheng, Bin Song, Ancheng Qin, Arvine Chandoo, Zhuo Shao, Jianwei Bi, Xiangqun Yang, Gang Jin, Xian Shen. OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM. Pancreatology 2019; 19(5): 751 doi: 10.1016/j.pan.2019.01.009
|
| 27 |
Yu-Lei Gu, Chao Lan, Hui Pei, Shuang-Ning Yang, Yan-Fen Liu, Li-Li Xiao. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Asian Pacific Journal of Cancer Prevention 2015; 16(15): 6569 doi: 10.7314/APJCP.2015.16.15.6569
|
| 28 |
Guofu Hu, Nan He, Chuanqi Cai, Fei Cai, Ping Fan, Zhikun Zheng, Xin Jin. HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer. Pancreatology 2019; 19(2): 383 doi: 10.1016/j.pan.2019.01.011
|
| 29 |
Zhenyong Wang. Diagnostic performance for declined microRNA‐133a in pancreatic cancer. Journal of Cellular Biochemistry 2020; 121(8-9): 3882 doi: 10.1002/jcb.29547
|
| 30 |
Jin Lu, Yongsheng Yang, Xiangliang Liu, Xiao Chen, Wei Song, Zefeng Liu. FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC. Cell Death & Disease 2023; 14(11) doi: 10.1038/s41419-023-06244-7
|
| 31 |
Xiaoyan Zhang, Ying Shi, Changqing Sun, Lei Guo, Hairong Zhang, Zhiyun Zhou, Dan Wang, Jing Yan, Linlin Dong, Qingxia Wang, Yueling Hu, Juan Sun. The Description of Pancreatic Cancer Death in Inner Mongolia 2008-2014. Open Journal of Epidemiology 2017; 7(02): 131 doi: 10.4236/ojepi.2017.72012
|
| 32 |
Rui Lin, Xunxia Bao, Hui Wang, Sibo Zhu, Zhongyan Liu, Quanning Chen, Kaixing Ai, Baomin Shi. TRPM2 promotes pancreatic cancer by PKC/MAPK pathway. Cell Death & Disease 2021; 12(6) doi: 10.1038/s41419-021-03856-9
|
| 33 |
Shiu-Jau Chen, Shao-Cheng Wang, Yuan-Chuan Chen. The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(23): 12836 doi: 10.3390/ijms222312836
|
| 34 |
Milena Ilic, Biljana Milicic, Irena Ilic. Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis . World Journal of Gastroenterology 2021; 27(20): 2643-2656 doi: 10.3748/wjg.v27.i20.2643
|
| 35 |
Qian Li, Xingxing Li, Xiaojun Yang, Bin Zhang, Yuqing Gu, Guangliang Gu, Jiageng Xiong, Yanan Li, Zhuyin Qian. Long Intergenic Nonprotein Coding RNA 173 Inhibits Tumor Growth and Promotes Apoptosis by Repressing Sphingosine Kinase 1 Protein Expression in Pancreatic Cancer. DNA and Cell Biology 2021; 40(6): 757 doi: 10.1089/dna.2020.6103
|
| 36 |
Magda H. Abdellattif, Ahmed Elkamhawy, Hossam Nada. Synthesis, Biological Evaluation, and In Silico Studies of New Heterocycles Incorporating 4,5,6,7-Tetrabromophthalimide Moiety as Potential Antibacterial and Anticancer Agents. HETEROCYCLES 2022; 104(5): 855 doi: 10.3987/COM-21-14535
|
| 37 |
Korosh Morshedi, Sarina Borran, Mohammad Saeid Ebrahimi, Mohammad Jaber Masoud khooy, Zeynab Sadat Seyedi, Atefeh Amiri, Mohammad Abbasi‐Kolli, Maryam Fallah, Haroon Khan, Amirhossein Sahebkar, Hamed Mirzaei. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytotherapy Research 2021; 35(9): 4834 doi: 10.1002/ptr.7119
|
| 38 |
Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan. Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211043030
|
| 39 |
Chen Luo, Yi Yu, Jinfeng Zhu, Leifeng Chen, Dan Li, Xingyu Peng, Zitao Liu, Qing Li, Qing Cao, Kai Huang, Rongfa Yuan. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell & Bioscience 2024; 14(1) doi: 10.1186/s13578-024-01213-9
|
| 40 |
Zhongbo Xu, Wenyan Yu, Lin Li, Guojuan Wang. Identification of pyroptosis-related gene signature for predicting prognosis of patients with pancreatic cancer using bioinformatics. Medicine 2022; 101(41): e31043 doi: 10.1097/MD.0000000000031043
|
| 41 |
Wen-liang Huang, Shu-fen Wu, Xiao Huang, Shan Zhou, Luca Falzone. Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/9453549
|
| 42 |
Kai-fei Wang, Yi-ping Mu, Shu Wang, Yin-xue Song, Jing Xu, Xiao-hui Li, Rui-tao Wang. NIR/PH-responsive erythrocyte membrane-camouflaged metal-organic framework for photothermal therapy of pancreatic cancer. Materials Today Communications 2023; 34: 105221 doi: 10.1016/j.mtcomm.2022.105221
|
| 43 |
Hengqing Zhu, Qing Li, Yulan Zhao, Hong Peng, Liangyun Guo, Jing Zhu, Zi Jiang, Zhaoxia Zeng, Bin Xu, Sisi Chen. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation. Oncogene 2021; 40(28): 4663 doi: 10.1038/s41388-021-01893-4
|
| 44 |
Guang Tan, Bing Li, YiJun Zhang, RengYin Zhang, Lin Wang, Fengjun Liu, Fei Shan. Targeted Fluorescence Imaging and Anti-Tumor Effects of QDs-NGR Nanoparticles on Pancreatic Cancer Cells. Science of Advanced Materials 2021; 13(12): 2475 doi: 10.1166/sam.2021.4163
|
| 45 |
Ningzi Tian, Dong Wu, Lei Zhu, Mengsu Zeng, Jianke Li, Xiaolin Wang. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00823-4
|
| 46 |
Kaiyuan Ji, Wenlong Dou, Ningfang Zhang, Bolun Wen, Mingyan Zhong, Qianbing Zhang, Shuxiang Xu, Jianlong Zhou, Jingfeng Liu. Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells. Cell Biology International 2023; 47(1): 144 doi: 10.1002/cbin.11917
|
| 47 |
Kebing Wang, Shuai Jiang, Anpei Huang, Ying Gao, Baogang Peng, Zhi Li, Wenbin Ma, Zhou Songyang, Shihong Zhang, Meifang He, Wen Li. GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.575358
|
| 48 |
Yongli Hu, Bing Wang, Lie Wang, Zhenran Wang, Zhiyuan Jian, Lin Deng. Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy. Molecular Medicine Reports 2020; 22(1): 398 doi: 10.3892/mmr.2020.11098
|
| 49 |
Yiping He, Yan Liu, Jianping Gong, Changan Liu, Hua Zhang, Hao Wu. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10041
|
| 50 |
Wenlong Wang, Weiyang Lou, Bisha Ding, Beng Yang, Hongda Lu, Qingzhi Kong, Weimin Fan. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging 2019; 11(9): 2610 doi: 10.18632/aging.101933
|
| 51 |
Xiaotong Zhang. A novel simple suture method for establishing an orthotopic pancreatic cancer mouse model: a comparative study with two conventional methods. American Journal of Translational Research 2024; 16(9): 4422 doi: 10.62347/JUDX2512
|
| 52 |
Wafaa A. Mokbel, Mona A. Hosny, Sobhi M. Gomha, Magdi E.A. Zaki, Basant Farag, Ahmed F. El Farargy, Areej Al Bahir, Yasser H. Zaki. Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents. Results in Chemistry 2024; 7: 101375 doi: 10.1016/j.rechem.2024.101375
|
| 53 |
Jianfei Huang, Haijun Mei, Zhiyuan Tang, Jieying Li, Xiaojing Zhang, Yixiang Lu, Fang Huang, Qin Jin, Zhiwei Wang. Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. Journal of Controlled Release 2017; 245: 1 doi: 10.1016/j.jconrel.2016.11.024
|
| 54 |
Xiaoqin Wang, Lifang Li, Yang Yang, Linlin Fan, Ying Ma, Feifei Mao. Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.832715
|
| 55 |
Greta Brezgyte, Vinay Shah, Daria Jach, Tatjana Crnogorac-Jurcevic. Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review. Cancers 2021; 13(11): 2722 doi: 10.3390/cancers13112722
|
| 56 |
Hao Xu, Lu Yin, Qianhui Xu, Jingjing Xiang, Rujun Xu. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02614-x
|
| 57 |
Shuxian Zhang, Qingqing Li, Huixiao Yuan, Ling Ren, Xuyang Liang, Shouying Li, Shengxiang Lv, Hua Jiang, Alamgeer Yuchi. Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Cancer by Regulating RNA Binding Motif Protein 14. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5091154
|
| 58 |
Yu Zeng, Haifeng Zhang, Minghui Zhu, Qingfan Pu, Jinhai Li, Xiao Hu. β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.904258
|
| 59 |
Jin Xu, Weixue Xu, Xuan Yang, Zhen Liu, Yiya Zhao, Qinyun Sun. LncRNA MIR99AHG mediated by FOXA1 modulates NOTCH2/Notch signaling pathway to accelerate pancreatic cancer through sponging miR-3129-5p and recruiting ELAVL1. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02189-z
|
| 60 |
Qiang Zhang, Shuai Hu, Kai Zuo, Yunyun Guo, Lansheng Li. Nanoalbumin particles carrying microRNA-200c sensitize gastric cancer cells to cisplatin through targeting of phosphatase and tensin homolog (PTEN) gene. Materials Express 2022; 12(5): 691 doi: 10.1166/mex.2022.2199
|
| 61 |
Rui Lin, Yufeng Wang, Quanning Chen, Zhongyan Liu, Shuai Xiao, Bingyi Wang, Baomin Shi. TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8816
|
| 62 |
Qing-Guo Liu, Yan-Ju Li, Lan Yao. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis. Pancreatology 2018; 18(6): 678 doi: 10.1016/j.pan.2018.07.003
|
| 63 |
Erhao Zhang, Peiwei Yang, Jieyi Gu, Heming Wu, Xiaowei Chi, Chen Liu, Ying Wang, Jianpeng Xue, Weiyan Qi, Qingbo Sun, Shengnan Zhang, Jialiang Hu, Hanmei Xu. Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy. Journal of Hematology & Oncology 2018; 11(1) doi: 10.1186/s13045-018-0646-9
|
| 64 |
Qiang Wang, Qichen Chai, Jin Chen, Jing Lv, Xiaofang Tang. Dihydromyricetin Inhibits Proliferation, Migration, and Invasion of Pancreatic Cancer Cells by Regulating miR-509-3p/PRMT5 Pathway. Journal of Biomaterials and Tissue Engineering 2021; 11(3): 392 doi: 10.1166/jbt.2021.2405
|
| 65 |
Ismail M. M. Othman, Mohamed A. M. Gad-Elkareem, Mohamed El-Naggar, Eman S. Nossier, Abd El-Galil E. Amr. Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies. Journal of Enzyme Inhibition and Medicinal Chemistry 2019; 34(1): 1259 doi: 10.1080/14756366.2019.1637861
|
| 66 |
Yuzheng Xue, Yao Zhong, Tielong Wu, Yingyue Sheng, Yuanyuan Dai, Lingling Xu, Chuanqing Bao. <p>Anti-Proliferative and Apoptosis-Promoting Effect of microRNA-125b on Pancreatic Cancer by Targeting NEDD9 via PI3K/AKT Signaling</p>. Cancer Management and Research 2020; : 7363 doi: 10.2147/CMAR.S227315
|
| 67 |
Daryl Ramai, Eric R. Smith, Yichen Wang, Yuting Huang, Itegbemie Obaitan, Saurabh Chandan, Banreet Dhindsa, Apostolis Papaefthymiou, John D. Morris. Epidemiology and Socioeconomic Impact of Pancreatic Cancer: An Analysis of the Global Burden of Disease Study 1990–2019. Digestive Diseases and Sciences 2024; 69(4): 1135 doi: 10.1007/s10620-024-08292-1
|
| 68 |
Youli Chen, Tianhui Chen, Jing-Yuan Fang. Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029. Cancer Letters 2023; 560: 216127 doi: 10.1016/j.canlet.2023.216127
|
| 69 |
Feng Yang, Chen Jin, Caifeng Zou, Yang Di, Sijie Hao, Haihui Huang, Andrew L. Warshaw, Deliang Fu. Delaying surgery after preoperative biliary drainage does not increase surgical morbidity after pancreaticoduodenectomy. Surgery 2019; 166(6): 1004 doi: 10.1016/j.surg.2019.07.012
|
| 70 |
Zhenyu Wang, Wenhao Shen, Xugang Li, Yang Feng, Kun Qian, Gaoren Wang, Yiying Gao, Xiaohui Xu, Shuyu Zhang, Ling Yue, Jianping Cao. <p>The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells</p>. Drug Design, Development and Therapy 2020; : 3099 doi: 10.2147/DDDT.S242557
|
| 71 |
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
|
| 72 |
Feng Yang, Xiaoyi Wang, Chen Jin, Hang He, Deliang Fu. Pancreatectomy with Hepatic Artery Resection for Pancreatic Head Cancer. World Journal of Surgery 2019; 43(11): 2909 doi: 10.1007/s00268-019-05106-8
|
| 73 |
Ji-Jun Zhang, Jie-peng Jia, Quan Shao, Ying-kai Wang. Diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies. Primary Care Diabetes 2019; 13(3): 276 doi: 10.1016/j.pcd.2018.11.015
|
| 74 |
Zhu Zhang, Kathy Ka-Wai Auyeung, Stephen Cho-Wing Sze, Shiqing Zhang, Ken Kin-Lam Yung, Joshua Ka-Shun Ko. The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A “TGF-β paradox”. Phytomedicine 2020; 68: 153177 doi: 10.1016/j.phymed.2020.153177
|
| 75 |
Yecheng Xu, Feng Yang, Deliang Fu. Prognostic value of para-aortic lymph node metastasis and dissection for pancreatic head ductal adenocarcinoma: a retrospective cohort study. Journal of Pancreatology 2024; 7(3): 199 doi: 10.1097/JP9.0000000000000159
|
| 76 |
Ran Xue, Lin Hua, Wenbin Xu, Yan Gao, Yanhua Pang, Jianyu Hao. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4283673
|
| 77 |
Xianbo Wu, Jie Wang, Qi Liang, Rongsheng Tong, Jianli Huang, Xinwei Yang, Yihua Xu, Wenjing Wang, Minghan Sun, Jianyou Shi. Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment. Biomedicine & Pharmacotherapy 2022; 151: 113116 doi: 10.1016/j.biopha.2022.113116
|
| 78 |
Tingke Tian, Quanzhong Yang, Cuijuan Zhang, Xiaokun Li, Jiancheng Cheng, Suhwan Chang. MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. PLOS ONE 2021; 16(5): e0249375 doi: 10.1371/journal.pone.0249375
|
| 79 |
Huang-bao Li, Jun Zhou, Fengqing Zhao, Jiayin Yu, Longsheng Xu. <p>Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer</p>. Cancer Management and Research 2020; : 5997 doi: 10.2147/CMAR.S251897
|
| 80 |
Songyuan Zheng, Dongyan Liu, Feifei Wang, Youyan Jin, Siqiao Zhao, Siyu Sun, Sheng Wang. ABCA12 Promotes Proliferation and Migration and Inhibits Apoptosis of Pancreatic Cancer Cells Through the AKT Signaling Pathway. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.906326
|
| 81 |
Xu-hong Fu, Xiong Zhang, Hong Yang, Xiao-wei Xu, Zong-long Hu, Juan Yan, Xing-ling Zheng, Rong-rui Wei, Zhu-qing Zhang, Shi-rui Tang, Mei-yu Geng, Xun Huang. CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression. Acta Pharmacologica Sinica 2019; 40(5): 677 doi: 10.1038/s41401-018-0108-5
|
| 82 |
Wei Wang, Haibo Xing, Changxin Huang, Hong Pan, Da Li. Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-1339-0
|
| 83 |
Fan Jiang, Hong‐S. Xing, Wei‐Y. Chen, Jie Du, Yue‐l. Ruan, An‐Y. Lin, Chi‐Z. Zhou. Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak‐1. Journal of Cellular Biochemistry 2019; 120(3): 4333 doi: 10.1002/jcb.27719
|
| 84 |
Xiangpeng Meng, Jia Ma, Baosheng Wang, Xin Wu, Zhen Liu. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Journal of Physiology and Biochemistry 2020; 76(2): 301 doi: 10.1007/s13105-020-00734-4
|
| 85 |
Andrés Moreno Roca, Luciana Armijos Acurio, Ruth Jimbo Sotomayor, Carlos Céspedes Rivadeneira, Carlos Rosero Reyes, Carlos López Ayala. Cohort study of the overall survival of patients with pancreatic cancer in a hospital of specialties of Quito-Ecuador in the period 2007–2017. Innovative Surgical Sciences 2021; 6(2): 75 doi: 10.1515/iss-2020-0030
|
| 86 |
Feng Yang, Yun Bao, Zhongwen Zhou, Chen Jin, Deliang Fu. Preoperative neutrophil‐to‐lymphocyte ratio predicts malignancy and recurrence‐free survival of solid pseudopapillary tumor of the pancreas. Journal of Surgical Oncology 2019; 120(2): 241 doi: 10.1002/jso.25484
|
| 87 |
Xiaojie Bian, Hanjue Dai, Jun Feng, Hongxia Ji, Yuting Fang, Nan Jiang, Wei Li. Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer. Medicine 2018; 97(22): e10988 doi: 10.1097/MD.0000000000010988
|
| 88 |
Jia‐Qiang Zhang, Shi Chen, Jiang‐Ning Gu, Yi Zhu, Qian Zhan, Dong‐Feng Cheng, Hao Chen, Xia‐Xing Deng, Bai‐Yong Shen, Cheng‐Hong Peng. Retracted: MicroRNA‐300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial‐mesenchymal transition via the Wnt/β‐catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. Journal of Cellular Biochemistry 2018; 119(1): 1027 doi: 10.1002/jcb.26270
|
| 89 |
Rong Fu, Zheng Lin, Fei He, Yixian Jiang, Zhenquan Zheng, Zhijian Hu. Trend of disparity between coastland and inland in medical expenditure burden for rural inpatients with malignant tumor in southeast of China from 2007 to 2016. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06769-6
|
| 90 |
Jiankun Gao, Gu Wang, Jingrong Wu, Yu Zuo, Jing Zhang, Xintian Jin. Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells. Molecular Therapy - Oncolytics 2019; 12: 214 doi: 10.1016/j.omto.2019.01.006
|
| 91 |
Li-Juan Gao, Jia-Lei Li, Rui-Rui Yang, Zhong-Mei He, Min Yan, Xia Cao, Ji-Min Cao. Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.884334
|
| 92 |
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang. Liquid biopsy in pancreatic cancer: the beginning of a new era. Oncotarget 2018; 9(42): 26900 doi: 10.18632/oncotarget.24809
|
| 93 |
Yihui Ma, Peiyi Xia, Zhengyang Wang, Jingjing Xu, Lan Zhang, Yanan Jiang. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1. Neoplasia 2021; 23(9): 912 doi: 10.1016/j.neo.2021.07.004
|
| 94 |
Chen Chang, Xiaofen Li, Dan Cao. Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08275-9
|
| 95 |
Xianglong Tan, Jinyong Lv, Guodong Zhao, Zhiming Zhao, Chenggang Li, Yong Xu, Minggen Hu. Retracted: MicroRNA‐4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of TrkA. The Journal of Gene Medicine 2017; 19(1-2) doi: 10.1002/jgm.2938
|
| 96 |
Guopeng Zhang, Dongbo Liu, Guoxian Long, Lei Shi, Hong Qiu, Guangyuan Hu, Guoqing Hu, Shunfang Liu. Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2. Tumor Biology 2017; 39(4): 101042831769836 doi: 10.1177/1010428317698364
|
| 97 |
Xiaohui Feng, Kexin Yang, Zeyu Feng, Yifan Xie, Wenjie Han, Qianqian Chen, Shulei Li, Yiqing Zhang, Yue Yu, Gang Zou. Selective and sensitive detection of miRNA-198 using single polymeric microfiber waveguide platform with heterogeneous CHA amplification strategy. Talanta 2022; 240: 123218 doi: 10.1016/j.talanta.2022.123218
|
| 98 |
Yang Gao, Xiang Fei, Lingming Kong, Xiaodong Tan. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway. Anti-Cancer Drugs 2020; 31(8): 828 doi: 10.1097/CAD.0000000000000948
|
| 99 |
Mustafa Ali Khan, Maryam Sherwani, Kaleem S. Ahmed, Mubeen Ali, Priya Ashok Kumar, Javeria Tariq, Leslie Christensen, Netsanet Bogale, Patrick B. Schwartz, Syed Nabeel Zafar. Morbidity and Mortality Following Surgery for Pancreatic Cancer in Low‐ and Middle‐Income Countries: A Systematic Review and Meta‐Analysis. Journal of Surgical Oncology 2024; doi: 10.1002/jso.27946
|
| 100 |
Chen Liu, He Cheng, Kaizhou Jin, Zhiyao Fan, Yitao Gong, Yunzhen Qian, Shengming Deng, Qiuyi Huang, Quanxing Ni, Xianjun Yu, Guopei Luo. Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy. Cancer Control 2020; 27(1) doi: 10.1177/1073274820915947
|
| 101 |
Wenzhe Si, Xujun Liu, Rui Wei, Yuan Zhang, Yang Zhao, Liyan Cui, Tianpei Hong. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Cell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1424-5
|
| 102 |
Bo Tang, Yihua Yang, Min Kang, Yunshan Wang, Yan Wang, Yin Bi, Songqing He, Fumio Shimamoto. m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-019-1128-6
|
| 103 |
Qiu Li, Peng Chen, Haikui Yang, Miaolan Luo, Wenwei You, Peiliang Zhao. Synthesis, antiproliferative evaluation, and structure–activity relationships of novel triazole–isoindoline hybrids bearing 3,4,5-trimethoxyphenyl moiety. Chemical Papers 2018; 72(3): 651 doi: 10.1007/s11696-017-0311-8
|
| 104 |
Zi-Han Zhang, Yi-Wen Bao, Ya-Jun Zhao, Jian-Quan Wang, Jin-Tao Guo, Si-Yu Sun. Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis. World Journal of Clinical Oncology 2023; 14(11): 504-517 doi: 10.5306/wjco.v14.i11.504
Abstract(379) |
Core Tip(423) |
Full Article(HTML)(1157)
|
Full Article with Cover (PDF)-5079K(61)
|
Full Article (Word)-1554K(26)
|
Audio-1609K(1)
|
Peer-Review Report-271K(43)
|
Answering Reviewers-111K(40)
|
Full Article (PDF)-4796K(80)
|
Full Article (XML)-149K(44)
|
Times Cited (2)
|
Total Visits (4005)
|
Open
|
| 105 |
Hongchao Han, Lisheng Wang, Jie Xu, Aikun Wang. miR‑128 induces pancreas cancer cell apoptosis by targeting MDM4. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6047
|
| 106 |
Xin‑Fang Hou, Shuai Li, Chen Wu, Ke Li, Shu‑Ning Xu, Ju‑Feng Wang. Effects of obatoclax combined with gemcitabine on the biological activity of pancreatic cancer cells under hypoxic conditions. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8932
|
| 107 |
Ruolei Zhong, Sheng Li, Kaifeng Fang, Liu Yang, Li Wang. microRNA-1225 inhibit apoptosis of pancreatic cancer cells via targeting JAK1. Cell Cycle 2019; 18(9): 990 doi: 10.1080/15384101.2019.1608127
|
| 108 |
Rong-Tao Zhou, Mei He, Ze Yu, Yang Liang, Yuzhe Nie, Sheng Tai, Chun-Bo Teng. Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of NEDD9 expression and its downstream Akt and ERK signaling pathways. Oncotarget 2017; 8(34): 56351 doi: 10.18632/oncotarget.16912
|
| 109 |
Yannan Zhang, Fangfang Zheng, Fan Wang, Xingqian Liu, Cong Xiang, Shiyu Fu, Kun Shen, Geng Liu. The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice. Biomedicines 2023; 11(11): 2962 doi: 10.3390/biomedicines11112962
|
| 110 |
Hongfei Tong, Zhen Huang, Hui Chen, Bin Zhou, Yi Liao, Zhaohong Wang. <p>Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway</p>. OncoTargets and Therapy 2020; : 9839 doi: 10.2147/OTT.S253691
|
| 111 |
Shelesh Krishna Saraswat, Bashar Shaker Mahmood, Freddy Ajila, Doaa Saadi Kareem, Mariem Alwan, Zainab H. Athab, Jalal Brism Shaier, Seyed Reza Hosseinifard. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers. Pathology - Research and Practice 2024; 255: 155190 doi: 10.1016/j.prp.2024.155190
|
| 112 |
Dhanasekhar Reddy, Ranjith Kumavath, Debmalya Barh, Vasco Azevedo, Preetam Ghosh. Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions. Molecules 2020; 25(16): 3596 doi: 10.3390/molecules25163596
|
| 113 |
Ruihua Xu, Xianjun Yu, Jihui Hao, Liwei Wang, Hongming Pan, Guohong Han, Jianming Xu, Yanqiao Zhang, Shujun Yang, Jia Chen, Jieer Ying, Guanghai Dai, Mingyu Li, Damir Begic, Brian Lu, Lin Shen. Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3887-z
|
| 114 |
Yanxia Jin, Weidong Wang, Qiyun Wang, Yueyang Zhang, Kashif Rafiq Zahid, Umar Raza, Yongsheng Gong. Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02572-4
|
| 115 |
Jun Hou, XueTao Li, Ke-Ping Xie. Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01309-7
|
| 116 |
Haoran Zhao, Yubao Zhang, Haishi Liu, Yunfeng Wang, Zengfu Song. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990–2019. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12835-0
|
| 117 |
Wenming Wu, Yi Miao, Yinmo Yang, Wenhui Lou, Yupei Zhao. Real-world study of surgical treatment of pancreatic cancer in China: annual report of China Pancreas Data Center (2016–2020). Journal of Pancreatology 2022; 5(1): 1 doi: 10.1097/JP9.0000000000000086
|
| 118 |
Shangqing Liu, Xinrui Yuan, Runyue Hu, Shujun Liang, Shaohua Feng, Yuhua Ai, Yu Zhang. Automatic Pancreas Segmentation via Coarse Location and Ensemble Learning. IEEE Access 2020; 8: 2906 doi: 10.1109/ACCESS.2019.2961125
|
| 119 |
Feng Yang, Chen Jin, De-Liang Fu, Andrew L Warshaw. Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges. World Journal of Gastroenterology 2019; 25(23): 2839-2845 doi: 10.3748/wjg.v25.i23.2839
|
| 120 |
Amir Mohamed, Ahmet Ayav, Arthur Belle, Xavier Orry, Jean-Baptiste Chevaux, Valerie Laurent. Pancreatic cancer in patients with chronic calcifying pancreatitis: Computed tomography findings – a retrospective analysis of 48 patients. European Journal of Radiology 2017; 86: 206 doi: 10.1016/j.ejrad.2016.11.018
|
| 121 |
Rongxiang Wu, Zhan Su, Le Zhao, Ruifeng Pei, Yiren Ding, Deqiang Li, Shuo Zhu, Lu Xu, Wei Zhao, Wuyuan Zhou, Mahmood S. Choudhery. Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis. Stem Cells International 2023; 2023: 1 doi: 10.1155/2023/6510571
|
| 122 |
Hui Zhang, Xuan Zhang, Xun Li, Wen‐Bo Meng, Zhong‐Tian Bai, Shao‐Zhen Rui, Zheng‐Feng Wang, Wen‐Ce Zhou, Xiao‐Da Jin. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Journal of Cellular Physiology 2019; 234(1): 619 doi: 10.1002/jcp.26816
|
| 123 |
Feng Yang, Chen Jin, Andrew L. Warshaw, Li You, Yishen Mao, Deliang Fu. Total pancreatectomy for pancreatic malignancy with preservation of the spleen. Journal of Surgical Oncology 2019; 119(6): 784 doi: 10.1002/jso.25377
|
| 124 |
Hongquan Qiu, Liang Zhang, Dongzhi Wang, Yu Zhang, Hongyu Cai, Haiyan Miao, Feihu Chu, Osamah Ibrahim Khalaf. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/4622877
|
| 125 |
Qi Ling, Holger Kalthoff. Transportome Malfunction in the Cancer Spectrum. Reviews of Physiology, Biochemistry and Pharmacology 2020; 181: 105 doi: 10.1007/112_2020_20
|
| 126 |
Feifan Xiao, Jian Pu, Qiongxian Wen, Qin Huang, Qinle Zhang, Birong Huang, Shanshan Huang, Aihua Lan, Yuening Zhang, Jiatong Li, Dong Zhao, Jing Shen, Huayu Wu, Yan He, Hongtao Li, Xiaoli Yang. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget 2017; 8(29): 48488 doi: 10.18632/oncotarget.17290
|
| 127 |
Zequn Li, Zefeng Xuan, Jian Chen, Wenfeng Song, Shiyu Zhang, Cheng Jin, Mengqiao Zhou, Shusen Zheng, Penghong Song. Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer. International Journal of Oncology 2020; 57(1): 161 doi: 10.3892/ijo.2020.5053
|
| 128 |
Mingbing Xiao, Tao Li, Yifei Ji, Feng Jiang, Wenkai Ni, Jing Zhu, Baijun Bao, Cuihua Lu, Runzhou Ni. S100A11 promotes human pancreatic cancer PANC‑1 cell proliferation and is involved in the PI3K/AKT signaling pathway. Oncology Letters 2017; doi: 10.3892/ol.2017.7295
|
| 129 |
Li You, Feng Yang, De-Liang Fu. Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas. World Journal of Gastrointestinal Oncology 2018; 10(7): 184-193 doi: 10.4251/wjgo.v10.i7.184
|
| 130 |
Cangang Zhang, Yueji Zou, Yanan Zhu, Yi Liu, Hui Feng, Fan Niu, Pengcheng He, Haibo Liu. Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.649326
|
| 131 |
Lei Zhang, Zhenyong Wang, Deshuai Kong, Xiulei Zhao, Xiongfei Chen, Wei Chai. Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells. Bioscience, Biotechnology, and Biochemistry 2020; 84(8): 1603 doi: 10.1080/09168451.2020.1762479
|
| 132 |
Lucila M. Perrotta de Souza, Jessica P.L. Moreira, Homero S. Fogaça, Ronir R. Luiz, Heitor S. de Souza. Pancreatic Cancer Incidence and Lethality Rates in Brazil. Pancreas 2017; 46(5): 699 doi: 10.1097/MPA.0000000000000791
|
| 133 |
Ming Jia, Dan Zhang, Chunxiang Zhang, Chunhong Li. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01134-6
|
| 134 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17): 10132 doi: 10.3390/ijms231710132
|
| 135 |
Danny Conde, Carlos Rey, Manuel Pardo, Andrea Recaman, Juan Carlos Sabogal Olarte. Hepatic artery lymph node relevance in periampullary tumors: A retrospective analysis of survival outcomes. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.963855
|
| 136 |
Xin Huang, Chongyu Zhao, Yuanxia Han, Shengping Li. Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1143073
|
| 137 |
Jun Xia, Tong Cao, Cong Ma, Ying Shi, Yu Sun, Z. Peter Wang, Jia Ma. miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer. Molecular Therapy - Nucleic Acids 2018; 13: 121 doi: 10.1016/j.omtn.2018.08.012
|
| 138 |
Oluseyi Abidoye, Young Min Cho, Sheena Bhushan, Comfort Adewunmi, Hasan Choudhury. Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study. F1000Research 2023; 12: 15 doi: 10.12688/f1000research.122872.1
|
| 139 |
Jin Long, Zhe Liu, Lian Hui. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2544-2
|
| 140 |
Jun Liang, Huangming Cao, Guangxue Wang, Liang Wei, Lin Dong, Guohan Chen, Qinchuan Li, Dongyi Zhu. TMPOP2 Inhibition Suppresses Pancreatic Cancer Cell Migration and Development by Repressing The JNK/STAT3 Pathway. Advanced Biology 2023; 7(12) doi: 10.1002/adbi.202300113
|
| 141 |
Hanxuan Wang, Yulin Li, Jincan Huang, Youwei Ma, Shaocheng Lyu, Ren Lang. Prognostic value of perioperative serum low-density lipoprotein cholesterol level for postoperative prognosis of pancreatic cancer: a retrospective study. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01851-x
|
| 142 |
Bin Zhang, Mei Meng, Shufen Xiang, Zhifei Cao, Xingdong Xu, Zhe Zhao, Tong Zhang, Bowen Chen, Ping Yang, Ye Li, Quansheng Zhou. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth. Biochemical Pharmacology 2019; 166: 70 doi: 10.1016/j.bcp.2019.05.010
|
| 143 |
Jiachen Zheng, Ming Zhao, Jiahui Li, Guoying Lou, Yanyan Yuan, Shizhong Bu, Yang Xi. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumor Biology 2017; 39(3): 101042831769502 doi: 10.1177/1010428317695020
|
| 144 |
Jingyuan Li, Guanqun Liao, Wenfang Sun, Ji Sun, Tai Sheng, Kaibin Zhu, Karen M. von Deneen, Yi Zhang. A 2.5D semantic segmentation of the pancreas using attention guided dual context embedded U-Net. Neurocomputing 2022; 480: 14 doi: 10.1016/j.neucom.2022.01.044
|
| 145 |
Xuan Zou, Jishu Wei, Zebo Huang, Xin Zhou, Zipeng Lu, Wei Zhu, Yi Miao. Identification of a six‐miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Medicine 2019; 8(6): 2810 doi: 10.1002/cam4.2145
|
| 146 |
Xingxing Su, Yishi Yang, Le Ma, Peng Luo, Kaicheng Shen, Haisu Dai, Yan Jiang, Ling Shuai, Zhipeng Liu, Jinshan You, Ke Min, Chunmeng Shi, Zhiyu Chen. <p>Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway</p>. OncoTargets and Therapy 2020; : 12213 doi: 10.2147/OTT.S284219
|
| 147 |
Min-Yue Yin, Li-Ting Xi, Lu Liu, Jin-Zhou Zhu, Li-Juan Qian, Chun-Fang Xu. Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China. World Journal of Clinical Cases 2022; 10(14): 4404-4413 doi: 10.12998/wjcc.v10.i14.4404
|
| 148 |
Liang Xue, Yan Shen, Zhenglong Zhai, Shusen Zheng. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. International Journal of Molecular Medicine 2020; doi: 10.3892/ijmm.2020.4561
|
| 149 |
Shengyun Huang, Huanhuan Chong, Xun Sun, Zhijian Wu, Qing Jia, Yongxue Zhang, Xiaoli Lan. The Value of 18F-FDG PET/CT in Diagnosing Pancreatic Lesions: Comparison With CA19-9, Enhanced CT or Enhanced MR. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.668697
|
| 150 |
Fangshi Xu, Zhengliang Zhang, Miao Yuan, Yidi Zhao, Yang Zhou, Honghong Pei, Ling Bai. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma. Cancer Investigation 2021; 39(1): 39 doi: 10.1080/07357907.2020.1834576
|
| 151 |
Fang-Fei Wang, Shao-Cheng Lyu, Zhang-Yong Ren, Xin Zhao, Ji-Qiao Zhu, Qiang He. Superior mesenteric artery‑first approach for resectable pancreatic head cancer. World Academy of Sciences Journal 2022; 4(5) doi: 10.3892/wasj.2022.169
|
| 152 |
Hanyi Chen, Lipeng Hao, Chen Yang, Bei Yan, Qiao Sun, Lianghong Sun, Hua Chen, Yichen Chen. Understanding the rapid increase in life expectancy in shanghai, China: a population-based retrospective analysis. BMC Public Health 2018; 18(1) doi: 10.1186/s12889-018-5112-7
|
| 153 |
Kaiqiong Wang, Zhiju Chen, Xin Qiao, Jinfang Zheng. LncRNA NORAD regulates the mechanism of the miR-532-3p/Nectin-4 axis in pancreatic cancer cell proliferation and angiogenesis. Toxicology Research 2023; 12(3): 425 doi: 10.1093/toxres/tfad026
|
| 154 |
Tongyi Zhang, Hongwei Wang, Zhiwei Cai, Siqi Zhang, Chongyi Jiang. RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1078076
|
| 155 |
Lichao Pan, Lin Zhou, Weijia Yin, Jia Bai, Rong Liu. miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4380
|
| 156 |
Yan Gong, Liang Zhang, Aiqun Zhang, Xin Chen, Peng Gao, Qiang Zeng, Aamir Ahmad. GATA4 inhibits cell differentiation and proliferation in pancreatic cancer. PLOS ONE 2018; 13(8): e0202449 doi: 10.1371/journal.pone.0202449
|
| 157 |
Hongbao Yang, Abdullahi Mohamed Said, Huimin Huang, Akuetteh Percy David Papa, Guihua Jin, Shijia Wu, Nengfang Ma, Linhua Lan, Fugen Shangguan, Qiyu Zhang. Chlorogenic acid depresses cellular bioenergetics to suppress pancreatic carcinoma through modulating c‐Myc‐TFR1 axis. Phytotherapy Research 2021; 35(4): 2200 doi: 10.1002/ptr.6971
|
| 158 |
Jie Shao, Qin Liu, Jie Shen, Xiaoping Qian, Jing Yan, Yahui Zhu, Xin Qiu, Changchang Lu, Lanqi Cen, Manman Tian, Juan Du, Baorui Liu. Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.799026
|
| 159 |
Xinye Qian, Wenru Zong, Liqing Ma, Zhoujing Yang, Wei Chen, Jun Yan, Jianghui Xu. MM-associated circular RNA downregulates microRNA-19a through methylation to suppress proliferation of pancreatic adenocarcinoma cells. Bioengineered 2022; 13(4): 9294 doi: 10.1080/21655979.2022.2051815
|
| 160 |
Lu Zhuang, Jia Guo, Yao Yao, Zhaoshen Li. miR‑205 targets runt‑related transcription factor�2 to inhibit human pancreatic cancer progression. Oncology Letters 2018; doi: 10.3892/ol.2018.9689
|
| 161 |
Ghaidaa Raheem Lateef Al-Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, Firas Rahi Alhachami, Shukhrat Ziyadullaev, Mahmoud Kandeel, Roua Abulkassim, R Sivaraman, Noora M Hameed, Rosario Mireya Romero Parra, Sajad Karampoor, Rasoul Mirzaei. The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancer. Future Oncology 2022; 18(38): 4209 doi: 10.2217/fon-2022-0574
|
| 162 |
Ying‑Bo Zhang, Hong‑Xin Fei, Jia Guo, Xiao‑Jie Zhang, Shu‑Liang Wu, Li‑Li Zhong. Dauricine suppresses the growth of pancreatic cancer in�vivo by modulating the Hedgehog signaling pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.10790
|
| 163 |
S. Yang, K.W. Yeoh, M.C.-S. Wong, O.W.-K. Mang, L.A. Tse. Disparities of birth cohort effects on pancreatic cancer incidence between the United States and urban China. ESMO Open 2021; 6(5): 100240 doi: 10.1016/j.esmoop.2021.100240
|
| 164 |
Vanessa L Gordon-Dseagu, Susan S Devesa, Michael Goggins, Rachael Stolzenberg-Solomon. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. International Journal of Epidemiology 2018; 47(2): 427 doi: 10.1093/ije/dyx232
|
| 165 |
Min Ai, Changyuan Wang, Zeyao Tang, Kexin Liu, Xiuli Sun, Tengyue Ma, Yanxia Li, Xiaodong Ma, Lei Li, Lixue Chen. Design and synthesis of diphenylpyrimidine derivatives (DPPYs) as potential dual EGFR T790M and FAK inhibitors against a diverse range of cancer cell lines. Bioorganic Chemistry 2020; 94: 103408 doi: 10.1016/j.bioorg.2019.103408
|
| 166 |
Li You, Lie Yao, Yi-Shen Mao, Cai-Feng Zou, Chen Jin, De-Liang Fu. Partial pancreatic tail preserving subtotal pancreatectomy for pancreatic cancer: Improving glycemic control and quality of life without compromising oncological outcomes. World Journal of Gastrointestinal Surgery 2020; 12(12): 491-506 doi: 10.4240/wjgs.v12.i12.491
|
| 167 |
Wenhe Zhu, Wei Zhang, Na Xu, Yawei Li, Junjie Xu, Hong Zhang, Yan Li, Shijie Lv, Wensen Liu, Huiyan Wang. Dihydroartemisinin induces apoptosis and downregulates glucose metabolism in JF-305 pancreatic cancer cells. RSC Advances 2018; 8(37): 20692 doi: 10.1039/C8RA00565F
|
| 168 |
Bhoomika B K, Kanmani K, G. Smilarubavathy. Early Detection of Pancreatic Cancer using Machine Learning Algorithm. 2024 5th International Conference on Mobile Computing and Sustainable Informatics (ICMCSI) 2024; : 202 doi: 10.1109/ICMCSI61536.2024.00036
|
| 169 |
Zhi-tao Dai, Li Ma, Ting-ting Cao, Lian Zhu, Man Zhao, Ning Li. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83648-5
|
| 170 |
Nan Li, Chunli Wang, Peng Zhang, Shengyi You. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9304
|
| 171 |
Di Feng, Jing Yuan, Qi Liu, Li Liu, Xu Zhang, Yali Wu, Yifan Qian, Liping Chen, Yan Shi, Mancang Gu. UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed, paraffin‑embedded and optimal cutting temperature‑embedded materials. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4898
|
| 172 |
Xu Han, Yihu Tang, Yawei Dai, Shuai Hu, Jingxin Zhou, Xiang Liu, Jinfu Zhu, Yanhu Wu. MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9. Gene 2019; 699: 94 doi: 10.1016/j.gene.2019.02.077
|
| 173 |
Qian Li, Chengbin Lei, Changliang Lu, Jingye Wang, Min Gao, Wei Gao. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death & Disease 2019; 10(10) doi: 10.1038/s41419-019-1896-3
|
| 174 |
Hao Yuan, Jinhui Liu, Li Zhao, Pengfei Wu, Guosheng Chen, Qun Chen, Peng Shen, Taoyue Yang, Shaoqing Fan, Bin Xiao, Kuirong Jiang. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.800268
|
| 175 |
Rulin Sun, Xujun He, Xiaoting Jiang, Houquan Tao. The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. Journal of Cellular Biochemistry 2021; 122(9): 934 doi: 10.1002/jcb.29533
|
| 176 |
Cheng-Fang Wang, Xian-Jie Shi. Generation and application of patient-derived xenograft models in pancreatic cancer research. Chinese Medical Journal 2019; 132(22): 2729 doi: 10.1097/CM9.0000000000000524
|
| 177 |
Duanmin Hu, Cunjin Su, Min Jiang, Yating Shen, Aiming Shi, Fenglun Zhao, Ruidong Chen, Zhu Shen, Junjie Bao, Wen Tang. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3. Biochemical and Biophysical Research Communications 2016; 471(2): 290 doi: 10.1016/j.bbrc.2016.01.169
|
| 178 |
Xia Liu, Yayun Zhou, Jiamin Peng, Bei Xie, Qiyang Shou, Jianchao Wang. Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00495
|
| 179 |
Wei Li, Zhengdong Jiang, Xue Xiao, Zheng Wang, Zheng Wu, Qingyong Ma, Lei Cao. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-κB pathway in pancreatic cancer cells. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4295
|
| 180 |
Jian-Qing Chen, Yuan-Ping Tao, Yong-Gang Hong, Hui-Fen Li, Zhi-Ping Huang, Xuan-Fu Xu, Liang-Kai Hu.
M
6
A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling
. Cell Cycle 2021; 20(23): 2507 doi: 10.1080/15384101.2021.1991122
|
| 181 |
Xia Liu, Xiang-yang Xiao, Qi-yang Shou, Jun-feng Yan, Long Chen, Hui-ying Fu, Jian-chao Wang. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology 2016; 193: 538 doi: 10.1016/j.jep.2016.09.047
|
| 182 |
旭升 张. Research Progress of GRP78 in Gastrointestinal Cancer. Advances in Clinical Medicine 2022; 12(12): 11430 doi: 10.12677/ACM.2022.12121647
|
| 183 |
Xuan Zhu, Xing Niu, Chunlin Ge. Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis. Cancer Biology & Therapy 2019; 20(6): 799 doi: 10.1080/15384047.2018.1564566
|
| 184 |
Ling Ma, Xiaodong Tian, Feng Wang, Zhengkui Zhang, Chong Du, Xuehai Xie, Marko Kornmann, Yinmo Yang. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma. Cancer Biology & Therapy 2016; 17(10): 1051 doi: 10.1080/15384047.2016.1219814
|
| 185 |
Juan Zeng, Heying Zhang, Yonggang Tan, Zhe Wang, Yunwei Li, Xianghong Yang. Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-03001-2
|
| 186 |
Min Li, Xiaohan Nie, Yilidan Reheman, Pan Huang, Shuailei Zhang, Yushuai Yuan, Chen Chen, Ziwei Yan, Cheng Chen, Xiaoyi Lv, Wei Han. Computer-Aided Diagnosis and Staging of Pancreatic Cancer Based on CT Images. IEEE Access 2020; 8: 141705 doi: 10.1109/ACCESS.2020.3012967
|
| 187 |
Peng‐cheng Deng, Wei‐bo Chen, Hui‐hua Cai, Yong An, Xin‐quan Wu, Xue‐min Chen, Dong‐lin Sun, Yu Yang, Long‐qing Shi, Yong Yang. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR‐613. Journal of Cellular and Molecular Medicine 2019; 23(11): 7222 doi: 10.1111/jcmm.14467
|
| 188 |
Shihui Lai, Yan Wang, Ting Li, Yihong Dong, Yihao Lin, Liang Wang, Shangeng Weng, Xiang Zhang, Chengjie Lin. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00844-0
|
| 189 |
Kun Liu, Shuxuan Song, Ting Fu, Yiwen Liu, Hui Zhang, Min Yan, Zhen He, Weilu Zhang, Haixia Su, Zhao Li, Zhaohua Ji, Zhongjun Shao. Spatiotemporal Trends in the Incidence of Gastrointestinal Neoplasms in Wuwei City of Northwestern China From 1995 to 2016: A Hospital-Based Retrospective Observational Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.712857
|
| 190 |
Peng Qin, Maolin Du, Shubi Wang, Xingguang Zhang, Yanling Wang, Tao Yan, Lehui Li, Xiaoqian Xu, Huiqiu Zheng, Liqun Gao, Di Yu, Mingzhu Niu, Hongwei Li, Ruijie Wu, Juan Sun. The waterfall pattern of suicide mortality in Inner Mongolia for 2008–2015. Journal of Affective Disorders 2019; 256: 331 doi: 10.1016/j.jad.2019.05.057
|
| 191 |
Hui Zhang, Xielin Feng, Mingyi Zhang, Aixiang Liu, Lang Tian, Wentao Bo, Haiqing Wang, Yong Hu. Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0728-y
|
| 192 |
Jiujie Cui, Feng Jiao, Qi Li, Zheng Wang, Deliang Fu, Jun Liang, Houjie Liang, Tingyi Xia, Tao Zhang, Yang Zhang, Guanghai Dai, Zhihong Zhang, Jian Wang, Yongrui Bai, Yuxian Bai, Feng Bi, Donghui Chen, Dan Cao, Jie Chen, Weijia Fang, Yong Gao, Jianwei Guo, Jihui Hao, Haiqing Hua, Xinyu Huang, Wenchao Liu, Xiufeng Liu, Da Li, Ji Li, Enxiao Li, Zhiwei Li, Hongming Pan, Lin Shen, Yongwei Sun, Min Tao, Chengfeng Wang, Fenghua Wang, Jianping Xiong, Taiping Zhang, Xuebin Zhang, Xianbao Zhan, Leizhen Zheng, Gang Ren, Tingting Zhang, Jun Zhou, Qingyong Ma, Shukui Qin, Chunyi Hao, Liwei Wang. Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Journal of the National Cancer Center 2022; 2(4): 205 doi: 10.1016/j.jncc.2022.08.006
|
| 193 |
Xiaobo Zhang, Feng Gao, Lei Zhou, Huaitao Wang, Gang Shi, Xiaodong Tan. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(9): 1529 doi: 10.3727/096504017X14888987683152
|
| 194 |
Yang Yang, Tao Cheng, Peng Xie, Lishan Wang, Hong Chen, Zhangjun Cheng, Jiahua Zhou. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug Development Research 2022; 83(1): 64 doi: 10.1002/ddr.21844
|
| 195 |
Zhibin Lin, Yao Chen, Zhaoxian Lin, Chunshan Chen, Yangyang Dong. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1. IUBMB Life 2018; 70(10): 1032 doi: 10.1002/iub.1917
|